Medicis Pharmaceutical Corp. (MRX) Tops Q3 EPS by 2c

Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q3 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $484.6 million versus the consensus estimate of $475.84 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Singapore exports surge 40.6% in July on electronics demand
• Canadian trade officials to meet U.S. counterparts in Washington Monday